Evidence map›Paper›PMID 31155503›Full record

ArticleStem cell reports2019

CCR5 Signaling Promotes Murine and Human Hematopoietic Regeneration following Ionizing Radiation.

Sadhna O Piryani, Angel Y F Kam, Uyen T Vu, Nelson J Chao, Phuong L Doan

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. SON is an essential mCell stem cell · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. The roles of CC chemokines in response to radiation.Radiation oncology (London, England) · 2022
    Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sadhna O PiryaniDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA.
Angel Y F KamDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA.
Uyen T VuDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA.
Nelson J ChaoDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA; Duke Cancer Institute, Duke University, 595 LaSalle Street, DUMC 103866, Durham, NC 27710, USA.
Phuong L DoanDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA; Duke Cancer Institute, Duke University, 595 LaSalle Street, DUMC 103866, Durham, NC 27710, USA. Electronic address: phuong.doan@duke.edu.
Duke University · USDuke Medical Center · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fateK08CA184552 · NCI · DUKE UNIVERSITY · PI DOAN, PHUONG LINH · 2014 to 2018
$639k
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
NCI NIH HHS K08 CA184552NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA021765NIH HHS S10 OD018164
6 · The paper itself

Abstract

Hematopoietic stem and progenitor cells (HSPCs) depend on regulatory cytokines from the marrow microenvironment. From an unbiased cytokine screen of murine marrow supernatants, we identified C-C motif chemokine ligand 5 (CCL5) as an endothelial cell-secreted hematopoietic growth factor. Following treatment with CCL5, hematopoietic regeneration is accelerated and survival is prolonged after radiation. In mice with deletion of Ccr5, hematopoietic regeneration is delayed compared to control mice. Deletion of Ccr5 specifically in hematopoietic cells was sufficient to delay regeneration, while the deletion of Ccr5 in stromal/endothelial cells was not. Mechanistically, CCL5 promotes hematopoietic cell cycling and cell survival. Like murine hematopoietic cells, human hematopoietic cells (cord blood, healthy marrow, and peripheral blood) increase CCR5 expression after radiation exposure to promote cell survival. These data establish that CCL5 and CCR5 signaling play critical roles in hematopoietic regeneration and could serve as therapeutic targets to shorten the duration of myelosuppression.

Indexed as

Radiation, IonizingSignal TransductionAnimalsBone MarrowCell CycleCell SurvivalChemokine CCL5Dose-Response Relationship, RadiationGene ExpressionHematopoiesisHematopoietic Stem CellsHumansImmunophenotypingMiceReceptors, CCR5CCR5 protein, mouseChemokine CCL5Receptors, CCR5CCL5CCR5endothelial cellhematopoietic cytokinehematopoietic growth factorhematopoietic microenvironmenthematopoietic stem cellRANTESregenerationvascular niche

Identifiers

PMID31155503
PMCPMC6626871
OpenAlexW2947916598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.